Literature DB >> 29516958

The role of NRAGE subcellular location and epithelial-mesenchymal transition on radiation resistance of esophageal carcinoma cell.

Xiaojing Chang1, Xiaoying Xue1, Yafang Zhang1, Ge Zhang1, Huandi Zhou1, Yanling Yang1, Yuge Ran1, Zhiqing Xiao1, Xiaohui Ge1, Huizhi Liu1.   

Abstract

BACKGROUND: Neurotrophin receptor-interacting MAGE homolog (NRAGE) has been considered as a tumor suppressor. In the previous study, we established human esophageal carcinoma resistance cell line TE13R120 and found the difference of NRAGE expression between TE13 and TE13R120 cells by gene microarray. Herein, we further discuss the possible molecular mechanism of NRAGE on participating the radiation sensitivity of esophageal carcinoma cells.
MATERIALS AND METHODS: We used colony formation assay to measure the surviving fraction and relevant radiobiological parameters. NRAGE expression was estimated by immunofluorescence and Western blot. Tumor growth factor-β (TGF-β) was used for inducing epithelial-mesenchymal transition (EMT) in TE13 cells to detect the relationship between NRAGE and EMT; the capacity of cell migration was also assessed by wound healing assay.
RESULTS: TE13R120 cells were showed significantly radioresistance compared with TE13. The D0, Dq, and N value of TE13R120 were all higher than those of TE13 (2.499, 1.991, and 2.219 vs. 2.242, 0.854, and 1.645), as well as SF2 (0.734 vs. 0.538). Results of immunofluorescences showed that NRAGE was mainly expressed in the nucleus of TE13R120 cells, but in TE13 cells, it was mainly in cytoplasm. In addition, EMT phenotype was observed in TE13R120 cells and TGF-β-induced EMT in TE13 cells, E-cadherin expression was decreased, but vimentin was upregulated. Furthermore, TE13 cells have a rising tendency in NRAGE nucleus expression after treatment with TGF-β. Results of wound healing assay showed that the cell migration of TE13R120 and TGF-β-induced EMT in TE13 cells were remarkably enhanced.
CONCLUSIONS: Our results indicate that NRAGE subcellular localization is related to radiation resistance of esophageal carcinoma cell and EMT may be involved in NRAGE subcellular location.

Entities:  

Keywords:  Epithelial–mesenchymal transition; esophageal carcinoma; neurotrophin receptor-interacting MAGE homolog; radiation resistance; subcellular location

Mesh:

Substances:

Year:  2018        PMID: 29516958     DOI: 10.4103/jcrt.JCRT_687_17

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  5 in total

1.  Inhibition of Delta-like Ligand 4 enhances the radiosensitivity and inhibits migration in cervical cancer via the reversion of epithelial-mesenchymal transition.

Authors:  Shan-Shan Yang; De-Yang Yu; Yu-Ting Du; Le Wang; Lina Gu; Yun-Yan Zhang; Min Xiao
Journal:  Cancer Cell Int       Date:  2020-07-28       Impact factor: 5.722

2.  Identifying In Vitro Cultured Human Hepatocytes Markers with Machine Learning Methods Based on Single-Cell RNA-Seq Data.

Authors:  ZhanDong Li; FeiMing Huang; Lei Chen; Tao Huang; Yu-Dong Cai
Journal:  Front Bioeng Biotechnol       Date:  2022-05-30

3.  Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling.

Authors:  Hana Jin; Jong-Sil Lee; Dong-Chul Kim; Young-Shin Ko; Gyeong-Won Lee; Hye-Jung Kim
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

4.  NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma.

Authors:  Huandi Zhou; Guohui Wang; Zhiqing Xiao; Yu Yang; Zhesen Tian; Chen Gao; Xuetao Han; Wei Sun; Liubing Hou; Junling Liu; Xiaoying Xue
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

5.  LncRNA EGOT/miR-211-5p Affected Radiosensitivity of Rectal Cancer by Competitively Regulating ErbB4.

Authors:  Chunxiang Li; Hengchang Liu; Ran Wei; Zheng Liu; Haipeng Chen; Xu Guan; Zhixun Zhao; Xishan Wang; Zheng Jiang
Journal:  Onco Targets Ther       Date:  2021-04-28       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.